Unicycive Therapeutics, Inc. (UNCY) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 7 transactions totaling $12.4K, demonstrating a bullish sentiment with $12.4K in net insider flow. The most recent transaction on Aug 25, 2025 involved a transaction of 652,900 shares valued at $0.
No significant insider buying has been recorded for UNCY in the recent period.
No significant insider selling has been recorded for UNCY in the recent period.
Based on recent SEC filings, insider sentiment for UNCY is bullish with an Insider Alignment Score of 100/100 and a net flow of $12.4K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Unicycive Therapeutics, Inc. (UNCY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading UNCY stock, having executed 7 transactions in the past 90 days. The most active insider is Brigitte Schiller (Executive), who has made 2 transactions totaling $12.4K.
Get notified when executives and directors at UNCY file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 25, 2025 | Aggarwal Gaurav | Executive | Conversion | 652,900 | $N/A | $0 | |
| Jul 11, 2023 | K. Gupta Shalabh | Executive | Option Exercise | 104,612 | $N/A | $0 | |
| Jul 11, 2023 | Gupta Pramod | Executive | Option Exercise | 41,845 | $N/A | $0 | |
| Jul 11, 2023 | Jermasek Douglas | Executive | Option Exercise | 104,612 | $N/A | $0 | |
| Jul 11, 2023 | Aggarwal Gaurav | Executive | Conversion | 3,470,152 | $N/A | $0 | |
| Jul 15, 2022 | Schiller Brigitte | Executive | Option Exercise | 26,738 | $N/A | $0 | |
| May 16, 2022 | Schiller Brigitte | Executive | Purchase | 15,000 | $0.83 | $12.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 1 | $12.4K | 100.0% |
Conversion(C) | 2 | $0 | 0.0% |
Exercise(M) | 4 | $0 | 0.0% |
Insiders at Unicycive Therapeutics, Inc. are accumulating shares at an accelerated pace. With 5 insiders making 7 transactions totaling $12.4K in purchases versus $0 in sales, the net buying activity of $12.4K signals strong executive confidence. Brigitte Schiller (Executive) leads the buying activity with $12.4K in transactions across all time.